home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Solving The Mystery Of Nicotine Addiction

 
  March, 5 2009 19:42
your information resource in human molecular genetics
 
     

Nicotine's ability to selectively activate its receptors in the brain, but not muscle, is explained in a study in Nature. The findings solve the chemical mystery of nicotine addiction.

If nicotine activated its receptors in muscles as potently as in the brain, smoking would cause intolerable and perhaps fatal muscle contractions - so how does the chemical discriminate? Dennis Dougherty and colleagues find that it's all due to a specific interaction that only occurs in the brain, between the positive charge of nicotine and a specific aromatic amino acid on the brain receptor. This 'cation-pi' interaction doesn't happen in muscle, even though the binding sites for nicotine have the same overall structure. The difference is probably due to a subtle difference in the binding pockets, which allows nicotine to bind more tightly to the neuronal receptor.

Author contact:

Dennis Dougherty (California Institute of Technology, Pasadena, CA, USA)
E-mail: dadougherty@caltech.edu

Abstract available online.

(C) Nature press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.